Comparison of three methods for measuring psoriasis severity in clinical studies (Part 1 of 2): change during therapy in Psoriasis Area and Severity Index, Static Physician's Global Assessment and Lattice System Physician's Global Assessment

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 29, Iss. 7, 2015-07 ,pp. : 1406-1414

John Wiley & Sons Inc

Access to resources Recommend Favorite

The SAPASI Is Valid and Responsive to Psoriasis Disease Severity Changes in a Multi‐Center Clinical Trial

By  

THE JOURNAL OF DERMATOLOGY, Vol. 26, Iss. 4, 1999-04 ,pp. : 210-215

John Wiley & Sons Inc

Access to resources Recommend Favorite

The TNFAIP3 polymorphism rs610604 both associates with the risk of psoriasis vulgaris and affects the clinical severity

By  

CLINICAL & EXPERIMENTAL DERMATOLOGY, Vol. 40, Iss. 4, 2015-06 ,pp. : 426-430

John Wiley & Sons Inc

Access to resources Recommend Favorite

Expression of Granulysin mRNA in the Human Megakaryoblastic Leukemia Cell Line CMK

By  

Acta Haematologica, Vol. 108, Iss. 1, 2002-07 ,pp. : 13-18

Karger

Access to resources Recommend Favorite

Time, Psoriasis Area and Severity Index and Dermatology Life Quality Index of patients with psoriasis who drop out of clinical trials on etanercept because of lack of efficacy: a pooled analysis from 10 clinical trials

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 178, Iss. 2, 2018-02 ,pp. : 400-405

John Wiley & Sons Inc

Access to resources Recommend Favorite